]]> 20120035357 http://www.patentstorm.us/applications/20120035351/description.html

A compound comprising one or more polysubstituted imidazolate anions coordinated to a metal selected from the group consisting of barium, strontium, magnesium, radium or calcium or mixtures ...
]]> 20120035351 http://www.patentstorm.us/applications/20120035255/description.html

]]> 20120035255 http://www.patentstorm.us/applications/20120035227/description.html

wherein R¹ to R⁴ are defined as in claim 1, the tautomers and the stereoisomers thereof, mixtures thereof, the prodrugs and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV ...
]]> 20120035158 http://www.patentstorm.us/applications/20120035157/description.html

wherein R¹, R², R⁴, G¹, G², L, Y and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of neutrophil ...
]]> 20120035157 http://www.patentstorm.us/applications/20120035147/description.html

The present invention provides a condensed pyrrolopyridine derivative which is useful as an active ingredient for a pharmaceutical composition, in particular, a pharmaceutical composition for preventing or treating diseases caused by undesirable cytokine signal transduction or diseases caused by abnormal cytokine signal transduction.

[Means for Solution]

The present inventors have extensively ...
]]> 20120034250 http://www.patentstorm.us/applications/20120034193/description.html

]]> 20120029189 http://www.patentstorm.us/applications/20120029188/description.html

A haloalkylsulfonanilide derivative represented by the formula (1) or an agrochemically acceptable salt thereof:

• • the formula (1):

wherein Z is —C(R₉)(R₁₀)— or ...
]]> 20120029187 http://www.patentstorm.us/applications/20120029186/description.html

]]> 20120029185 http://www.patentstorm.us/applications/20120029177/description.html

The compounds of the present invention can easily be taken up to cancer cells as they contain amino acid residues thereof; radioactive or nonradioactive metals can be labeled ...
]]> 20120029177 http://www.patentstorm.us/applications/20120029167/description.html

]]> 20120029167 http://www.patentstorm.us/applications/20120028978/description.html

or pharmaceutically acceptable salts thereof. In another aspect, the invention provides methods for treatment of diseases or disorders mediated by a protein kinase, comprising administering a therapeutically effective amount of a compound of this ...
]]> 20120028966 http://www.patentstorm.us/applications/20120028965/description.html

wherein

• P: substituted 6-membered aromatic ring,
• Q: (substituted) 6-membered aromatic ring,
• ]]> 20120028962 http://www.patentstorm.us/applications/20120028961/description.html
• Application Number:  20120028961
• Publication Date:  2012-02-02
• Inventors:  Galka, Christopher Stanley; Williams, Andrew Caerwyn; Boyd, Steven Armen; Briner, Karin; Martinez-Grau, Maria Angeles; Cohen, Michael Philip; Rothhaar, Roger Ryan; Hellman, Sarah Lynne; Reinhard, Matthew Robert; Singh, Ajay; ALLEN, JOHN GORDON; Rodriguez, Michael John; Tidwell, Michael Wade; Victor, Frantz; Zhang, Deyi; Conway, Richard Gerard; Deo, Arundhati S.; Lee, Wai-Man; Siedem, Christopher Stephen; MAZANETZ, Michael Philip

where:

• • ]]> 20120028961 http://www.patentstorm.us/applications/20120028959/description.html
  • Application Number:  20120028959
  • Publication Date:  2012-02-02
  • Inventors:  Arlt, Michael; Schwarz, Matthias; Subramanya, Hosahalli; Thunuguntla, Siva Sanjeeva Rao; Kunnam, Satish Reddy; Sanivaru Vijay, Sekhar Reddy; Bingi, Chakrapani; Kusanur, Raviraj
  The invention relates to compounds of formula (I) wherein R¹, R², X¹, X², Y, R^a, R^b, Q have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis and also in the treatment of cancer disorders.

  ]]> 20120028959 http://www.patentstorm.us/applications/20120028958/description.html

• Application Number:  20120028958
• Publication Date:  2012-02-02
• Inventors:  KESSLER, Dirk; SCHNEIDER, Siegfried; van der VEEN, Lars; WUNBERG, Tobias

wherein

R¹ to R⁴ R³ are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned ...
]]> 20120028958 http://www.patentstorm.us/applications/20120028957/description.html

• • wherein
  • R¹ to R³ are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and the use thereof for ...
    ]]> 20120028952 http://www.patentstorm.us/applications/20120028945/description.html
  • Application Number:  20120028945
  • Publication Date:  2012-02-02
  • Inventors:  Bianchi, Giuseppe; Ferrari, Patrizia; Ferrandi, Mara
  Compound of formula (I), wherein the symbol have the meaning reported in the text; for preparing a medicament for the prevention and/or treatment of proteinuria, glomerulosclerosis or renal ...
  ]]> 20120028945 http://www.patentstorm.us/applications/20120028931/description.html
• Application Number:  20120028931
• Publication Date:  2012-02-02
• Inventors:  Graziani, Davide; Guarneri, Luciano; Leonardi, Amedeo; Riva, Carlo; Motta, Gianni; Marinoni, Fabio; Bettinelli, Ilaria

• (R₁ is an optionally substituted C₁-C₁₃ heteromonocyclic, heterobicyclic or heterotricyclic group containing from 1 to 5 heteroatoms selected from N, O and S;
• R₂ is H, an optionally substituted monocyclic aromatic group, or a C₁-C₅ heteroaromatic group containing from 1 to 4 ...
  ]]> 20120028931 http://www.patentstorm.us/applications/20120028926/description.html
• Application Number:  20120028926
• Publication Date:  2012-02-02
• Inventors:  Saha, Uttam; Petkovich, P. Martin; Helvig, Christian F.

• • where R² represents a hydrogen atom or a lower alkyl group;
  • A represents a lower alkylene group or lower alkenylene group; and
  • R^{1 ...
    ]]> 20120028920 http://www.patentstorm.us/applications/20120028919/description.html}
  • Application Number:  20120028919
  • Publication Date:  2012-02-02
  • Inventors:  Josef, Kurt A.; Dorsey, Bruce D.; Breslin, Henry J.; Dunn, Derek D.; Milkiewicz, Karen L.; Chatterjee, Sankar; Theroff, Jay P.; Weinberg, Linda; Hostetler, Greg A.; Tripathy, Rabindranath; Zificsak, Craig A.; Sundar, Babu G.; Diebold, James L.; Gingrich, Diane E.; Underiner, Theodore L.; Hudkins, Robert L.; Hunter, Rachael; Lisko, Joseph; Mesaros, Eugen F.; Ott, Gregory R.; Thieu, Tho; Wells, Gregory J.
  The present invention provides a compound of formula I

  or a salt form thereof, wherein Q¹, Q², Q³, and Q⁴ are as defined herein. The compound of formula I has ALK and/or JAK2 inhibitory activity, and may be used to treat proliferative ...
  ]]> 20120028919 http://www.patentstorm.us/applications/20120028908/description.html

• Application Number:  20120028908
• Publication Date:  2012-02-02
• Inventors:  Leanna, Robert; Rasmussen, Michael; Chen, Shuang; Zhang, Geoff; Bartelt, Larry; Dhaon, Madhup; Henry, Rodger; Borchardt, Thomas; VISWANATH, Shekhar

]]> 20120027796 http://www.patentstorm.us/applications/20120022250/description.html

wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group;
E is lower alkylene;
X is S, O, or NR¹;
R¹ is a hydrogen atom or lower alkyl;
R^2a, R^2b, R^3a, R^3b, R^4a and R^{4b ...
]]> 20120022249 http://www.patentstorm.us/applications/20120022248/description.html}